Allogeneic transplants of canine peripheral blood stem cells mobilized by recombinant canine hematopoietic growth factors

Blood

Volumn 87, Issue 8, 1996, Pages 3508-3513

  Sandmaier, Brenda M ^a,b   Storb, Rainer ^a   Santos, Erlinda B ^a   Krizanac Bengez, Ljiljana ^a   Lian, Tianshun ^a   McSweeney, Peter A ^a   Yu, Cong ^a   Schuening, Friedrich G ^a   Deeg, H Joachim ^a   Graham, Theodore ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEMOPOIETIC GROWTH FACTOR; RECOMBINANT COLONY STIMULATING FACTOR 1; RECOMBINANT GROWTH HORMONE; GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT PROTEIN; STEM CELL FACTOR;

ALLOGENIC BONE MARROW TRANSPLANTATION; ANIMAL CELL; ARTICLE; DOG; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; ANIMAL; COMPARATIVE STUDY; DRUG EFFECT; DRUG POTENTIATION; FEMALE; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY; MALE; MIXED LYMPHOCYTE CULTURE; RADIATION CHIMERA;

ANIMALS; DOGS; DRUG SYNERGISM; FEMALE; GRAFT SURVIVAL; GRAFT VS HOST DISEASE; GRANULOCYTE COLONY-STIMULATING FACTOR; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HISTOCOMPATIBILITY; LYMPHOCYTE CULTURE TEST, MIXED; MALE; RADIATION CHIMERA; RECOMBINANT PROTEINS; STEM CELL FACTOR;

EID: 0029664796     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.8.3508.bloodjournal8783508     Document Type: Article

References (32)

1. Storb R, Epstein RB, Thomas ED: Marrow repopulating ability of peripheral blood cells compared to thoracic duct cells. Blood 32:662, 1968
2. Storb R, Epstein RB, Ragde H, Thomas ED. Marrow engraftment by allogeneic leukocytes in lethally irradiated dogs. Blood 30:805, 1967
3. Storb R, Epstein RB, Ragde H, Thomas ED: Marrow grafts by combined marrow and leukocyte infusions in unrelated dogs selected by histocompatibility typing. Transplantation 6.587, 1968
4. Storb R, Graham TC, Epstein RB, Sale GE, Thomas ED. Demonstration of hemopoietic stem cells in the peripheral blood of baboons by cross circulation. Blood 50.537, 1977
5. Storb R, Doney KC, Thomas ED, Appelbaum F, Buckner CD, Clift RA, Deeg HJ, Goodell BW, Hackman R, Hansen JA, Sanders J, Sullivan K, Weiden PL, Witherspoon RP: Marrow transplantation with or without donor buffy coat cells for 65 transfused aplastic anemia patients. Blood 59:236, 1982
6. Storb R, Prentice RL, Sullivan KM, Shulman HM, Deeg HJ, Doney KC, Buckner CD, Clift RA, Witherspoon RP, Appelbaum FR, Sanders JE, Stewart PS, Thomas ED: Predictive factors in chronic graft-versus-host disease in patients with aplastic anemia treated by marrow transplantation from HLA-identical siblings. Ann Intern Med 98:461, 1983
7. Sullivan KM, Storb R, Buckner CD, Fefer A, Fisher L, Weiden PL, Witherspoon RP, Appelbaum FR, Banaji M, Hansen J, Martin P, Sanders JE, Singer J, Thomas ED: Graft-versus-host disease as adoptive immunotherapy in patients with advanced hematologic neoplasms. N Engl J Med 320:828, 1989
8. Bensinger W, Singer J, Appelbaum F, Lilleby K, Longin K, Rowley S, Clarke E, Clift R, Hansen J, Shields T, Storb R, Weaver C, Weiden P, Buckner CD: Autologous transplantation with peripheral blood mononuclear cells collected after administration of recombinant granulocyte stimulating factor. Blood 81:3158, 1993
9. Scheding S, Brugger W, Mertelsmann R, Kanz L: Peripheral blood stem cells: In vivo biology and therapeutic potential. Stem Cells 12:203, 1994 (suppl 1)
10. Bolwell BJ, Goormastic M, Yanssens T, Dannley R, Baucco P, Fishleder A: Comparison of G-CSF with GM-CSF for mobilizing peripheral blood progenitor cells and for enhancing marrow recovery after autologous bone marrow transplant. Bone Marrow Transplant 14:913, 1994
11. Schneider JG, Crown JP, Wasserheit C, Kritz A, Wong G, Reich L, Norton L, Moore MA: Factors affecting the mobilization of primitive and committed hematopoietic progenitors into the peripheral blood of cancer patients. Bone Marrow Transplant 14:877, 1994
12. Schenkein DP, Dixon P, Desforges JF, Berkman E, Erban JK, Ascensao JL, Miller KB: Phase I/II study of cyclophosphamide, carboplatin, and etoposide and autologous hematopoietic stem-cell transplantation with posttransplant interferon alpha-2B for patients with lymphoma and Hodgkins disease. J Clin Oncol 12:2423, 1994
13. Bensinger WI, Weaver CH, Appelbaum FR, Rowley S, Demirer T, Sanders J, Storb R, Buckner CD: Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Blood 85:1655, 1995
14. Korbling M, Przepiorka D, Huh YO, Engel H, van Besien K, Giralt S, Andersson B, Kleine HD, Seong D, Deisseroth AB, Andreeff M, Champlin R: Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma. Potential advantage of blood over marrow allografts. Blood 85:1659, 1995
15. Schmitz N, Dreger P, Suttorp M, Rohwedder EB, Haferlach T, Löffler H, Hunter A, Russell NH: Primary transplantation of allogeneic peripheral blood progenitor cells mobilised by Filgrastim (G-CSF). Blood 85.1666, 1995
16. de Revel T, Appelbaum FR, Storb R, Schuening F, Nash R, Deeg J, McNiece I, Andrews R, Graham T: Effects of granulocyte colony stimulating factor and stem cell factor, alone and in combination, on the mobilization of peripheral blood cells that engraft lethally irradiated dogs. Blood 83:3795, 1994
17. Bull RW, Vriesendorp HM, Cech R, Grosse-Wilde H, Bijma AM, Ladiges WL, Krumbacher K, Doxiadis I, Ejima H, Templeton J, Albert ED, Storb R, Deeg HJ: Joint Report of the Third International Workshop on Canine Immunogenetics. II. Analysis of the serological typing of cells. Transplantation 43:154, 1987
18. Burnett RC, DeRose SA, Storb R: A simple restriction fragment length polymorphism assay for MHC class II gene testing of dog families. Transplantation 57:280, 1994
19. Wagner JL, DeRose SA, Burnett RC, Storb R. Brief communication: Nucleotide sequence and polymorphism analysis of canine DRA cDNA clones. Tissue Antigens 45:284, 1995
20. n polymorphisms to determine the origin of blood cells after allogeneic canine marrow grafting. Transplantation 58:701, 1994
21. Thomas ED, LeBlond R, Graham T, Storb R: Marrow infusions in dogs given midlethal or lethal irradiation. Radiat Res 41:113, 1970
22. Deeg HJ, Storb R, Longton G, Graham TC, Shulman HM, Appelbaum F, Thomas ED: Single dose or fractionated total body irradiation and autologous marrow transplantation in dogs: Effects of exposure rate, fraction size and fractionation interval on acute and delayed toxicity. Int J Radiat Oncol Biol Phys 15:647, 1988
23. Ladiges WC, Storb R, Graham T, Thomas ED: Experimental techniques used to study the immune system of dogs and other large animals, in Gay WI, Heavener JE (eds): Methods of Animal Experimentation, vol 7, part C. New York, NY, Academic, 1989, p 103
24. Schuening F, Storb R, Goehle S, Meyer J, Graham T, Deeg HJ, Pesando J: Canine pluripotent hemopoietic stem cells and CFU-GM express 1a-like antigens as recognized by two different class-II specific monoclonal antibodies. Blood 69:165, 1987
25. Raff RF, Storb R, Ladiges WC, Deeg HJ: Recognition of target cell determinants associated with DLA-D-locus-encoded antigens by canine cytotoxic lymphocytes. Transplantation 40:323, 1985
26. Moore PF, Rossitto PV, Danilenko DM, Wielenga JJ, Raff RF, Severns E: Monoclonal antibodies specific for canine CD4 and CD8 define functional T-lymphocyte subsets and high density expression of CD4 by canine neutrophils. Tissue Antigens 40:75, 1992
27. Sandmaier BM, Storb R, Appelbaum FR, Gallatin WM: An antibody that facilitates hematopoietic engraftment recognizes CD44. Blood 76:630, 1990
28. Krakowka S: Natural killer cell activity in adult gnotobiotic dogs. Am J Vet Res 44:635, 1983
29. Loughran TP, Jr., Deeg HJ, Storb R: Morphologic and phenotypic analysis of canine natural killer cells: Evidence for T-cell lineage. Cell Immunol 95:207, 1985
30. Storb R, Deeg HJ: Failure of allogeneic canine marrow grafts after total body irradiation: Allogeneic "resistance" vs transfusion induced sensitization Transplantation 42:571, 1986
31. Gerritsen WR, O'Reilly RJ: Granulocyte colony-stimulating factor (CSF) but not interleukin-1 (IL-1), IL-3, and granulocyte-macrophage CSF protect bone marrow progenitor cells from suppression by allosensitized cytotoxic T cells Blood 84:1906, 1994
32. Bensinger WI, Clift RA, Anasetti C, Appelbaum FR, Demirer T, Rowley S, Sandmaier BM, Torok-Storb B, Storb R, Buckner CD: Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor. Stem Cells 14:90, 1996